-

Sproutly Enters into LOI with CannaHive Inc.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”), has executed a Letter of Intent (the “LOI”) to enter into a commercial relationship with CannaHive Inc. (“CannaHive”). The agreement will allow Sproutly to further expand its Cannabis 2.0 product offerings produced by the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”).

Sproutly will leverage CannaHive’s proprietary manufacturing and packaging equipment and intellectual property to produce cannabis dissolvable powder at THR’s licensed facility. This agreement follows closely on the heels of the LOI with Cannabis Manufacturer’s Guild Ltd. (“CMG”). These relationships will provide synergies for the branding, commercialization, and distribution of a portfolio of cannabis products through THR’s existing agreements with multiple provinces in Canada.

“As we focus on the Cannabis 2.0 market in Canada, partnering with CannaHive and CMG will allow us to better utilize our THR operations to produce, package, and sell a larger portfolio of products.” said Dr. Arup Sen, Chief Executive Officer and Director of Sproutly. “CannaHive’s proprietary position in manufacturing certain products with established consumer appeal will allow us to leverage our licensed facility to realize additional revenue opportunities that benefit both CannaHive and Sproutly.”

About Sproutly Canada, Inc.

Sproutly’s core objective is to become the leading supplier of unique ingredients and customized formulations to the cannabis beverage and edibles market. Our natural water-soluble Infuz2O and BioNatural Oils will deliver revolutionary brands to international markets that are striving to produce a diverse portfolio of differentiated consumer products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide.

For more information on Sproutly, please visit: www.sproutly.ca.

About CannaHive Inc.

CannaHive is a privately owned manufacturing management service provider. They transfer technology and know-how from the pharmaceutical industry to the cannabis space through projects tailored to existing licensed facilities' characteristics. CannaHive sets up white label and private label programs to manufacture and package cannabis 2.0 products, which turn licensed producers looking to reduce their expenditures and raise their profitability into innovative players in the industry.

For more information on CannaHive Inc., please visit: www.cannahive.ca

Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, timing relating to the Company's ability to complete a definitive agreement with CannaHive and launch additional products.

These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company’s inability to launch or supply its products in Canada; the Company's inability to complete a definitive agreement with CannaHive and launch additional products; potential negative consumer, investor or public perception of the additional product lines; changes in consumer preferences and product trends; and political, legal and regulatory uncertainty relating to cannabis products generally. In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the Company will launch its products in Canada; that the Company’s products will be positively received by consumers in Canada; and that the Company will continue to develop and launch its Cannabis 2.0 products. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

Contacts

Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc.
Email: investors@sproutly.ca

Thierry Gervais, Chief Operating Officer and Director of CannaHive, Inc.
Email: info@cannahive.ca

Sproutly Canada, Inc.

CNSX:SPR

Release Versions

Contacts

Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc.
Email: investors@sproutly.ca

Thierry Gervais, Chief Operating Officer and Director of CannaHive, Inc.
Email: info@cannahive.ca

More News From Sproutly Canada, Inc.

Sproutly Announces Financial Results for the Third Quarter of Fiscal 2022

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sproutly Canada, Inc. (CSE: SPR) (FRA: 38G) (OTCQB: SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the third quarter ended November 30, 2021. Highlights for the Third Quarter Ended November 30, 2021 The Company settled outstanding current debt of the Company and the Company’s subsidiary, Toronto Herbal Remedies Inc., in the aggregate amount of $145,448.44, pursuant to the terms of debt settlement agreements...

Sproutly Issues Shares in Lieu of Semi-Annual Interest Payment

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") announces that, pursuant to a convertible debenture indenture dated October 24, 2018 between the Company and TSX Trust Company, as trustee, which has been amended pursuant to a first supplemental indenture dated April 24, 2020, a second supplemental indenture dated July 23, 2020, a third supplemental indenture dated September 23, 2020 and a fourth supplemental i...

Sproutly Announces Financial Results for the Second Quarter of Fiscal 2022

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sproutly Canada, Inc. (CSE: SPR) (FRA: 38G) (OTCQB: SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the second quarter ended August 31, 2021. "We continued to make progress in the development of our 2.0 products through the first half of fiscal 2022, as well as establishing the necessary groundwork with the partnership with Kingston Cannabis Inc. (“KCI”)” said Dr. Arup Sen, Chief Executive Officer and Directo...
Back to Newsroom